Lhasa Limited shared knowledge shared progress
Loading...

Publications

Jump to results
Authors
Publication Type
Publication Year
Related Products
Reset
New search
Publications search results
TitlePublishedTypeProducts
Generation of novel in chemico in vitro skin sensitisation data to evaluate the human relevance of defined approachespdf fileDerek Nexus
From Private Data to Shared Knowledgepdf fileEffiris
Predicting the safety of medicines in pregnancy: A workshop reportKaptis
ICH M7 Workshop - 2020 ICH M7 India Roadshowspdf fileDerek NexusSarah NexusZenethViticSetariaMirabilis
Predictions, Data and ICH M7 - 2020 ICH M7 India Roadshowspdf fileDerek NexusSarah NexusViticSetaria
Lhasa and the ICH M7 Guideline - 2020 ICH M7 India Roadshowpdf fileDerek NexusSarah NexusViticSetariaMirabilis
GSK MI risk assessment process Camicinal at al - 2020 ICH M7 India Roadshowpdf fileDerek NexusSarah NexusVitic
Hazard Assessment of Potentially Mutagenic Impurities - 2020 ICH M7 India Roadshowspdf fileDerek NexusSarah Nexus
ICH M7 - Regulatory Updates and Industry Practices - 2020 ICH M7 India Roadshowspdf fileDerek NexusSarah Nexus
Lhasa Expert Review Developments - 2020 ICH M7 India Roadshowspdf fileDerek NexusSarah NexusVitic
Management of N-Nitrosamines - Use of Mirabilis based purge calculations to understand MI related risk and control strategy options - RecordingMirabilis
Quantitative Analysis of In Vivo Dose-Response Data for Risk Assessment and Regulatory Decision Making - Recording
Management of N-Nitrosamines - Use of Mirabilis based purge calculations to understand MI related risk and control strategy optionspdf fileMirabilis
Quantitative Analysis of In Vivo Dose-Response Data for Risk Assessment and Regulatory Decision Making - A Case Study of Alkylnitrosaminespdf file
Future Developments AOP Networks And Predicting Secondary Pharmacologypdf fileEffirisKaptis
Carcinogenicity Adverse Outcome Pathwayspdf fileDerek NexusKaptisVitic
Beyond Mutagenicity: Supporting Toxicity Assessments For Other Endpointspdf fileDerek Nexus
Setaria 3.1.1 Installation Guidepdf fileSetaria
The use of in-silico tools to assist in the practical management of impurities under ICH M7.
Approaches to Skin Sensitisation Predictionpdf fileDerek Nexus
Data Sharing with Lhasapdf fileDerek Nexus
Improving performance of structural alerts for the in vitro mutagenicity endpoint using proprietary data - Rachael Tennantpdf fileDerek Nexus
Using an Adverse Outcome Pathway framework to ground approaches in predictive toxicologypdf file
Undertaking expert review under the ICH M7 guidelines - Chris Barberpdf file
Use of Mirabilis based purge calculations to understand MI related risk and control strategy options - Chris Barberpdf fileMirabilis

© 2021 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Apart from the free survey software, we also have access to QuestionPro's free survey templates . We've found many of them useful and powerful to collect insights from various stakeholders of our organization.